Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NCC126-0083 in Healthy Male Japanese Subjects.

NCT00722540 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00722540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00722540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NCC126-0083 in Healthy Male Japanese Subjects.
Lead sponsor
Novo Nordisk A/S
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2008
Completion date
April 30, 2009
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone disorder, healthy